Skip to content

Nasal Airflow in Post-operative Patients

Impacts of F&P Tui on Cortical Activity in Invasively Ventilated Post-operative Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07468266
Enrollment
12
Registered
2026-03-12
Start date
2026-03-01
Completion date
2027-02-01
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Invasive Ventilation

Brief summary

The goal of this investigation is to examine the effect of nasal airflow in invasively ventilated adult patients following planned surgery. The main questions it aims to answer are: * Does the investigational device produce an effect measured by EEG? * Are there differences in effect with modified airflow states?

Interventions

DEVICETUI-1

Provision of airflow to the nasal cavity by F\&P Tui at baseline rate

DEVICETUI-2

Provision of airflow to the nasal cavity by F\&P Tui at modified rate

Sponsors

Fisher and Paykel Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults \>18 years of age * Receiving sedation via propofol and fentanyl * Undergoing surgical procedure with planned post-operative invasive ventilation

Exclusion criteria

* Pre-existing neurological injury or condition

Design outcomes

Primary

MeasureTime frameDescription
Power spectral density of EEGBefore and 10 minutes after initiation of nasal airflowMean PSD will be calculated across beta, alpha, delta and gamma frequency bands

Secondary

MeasureTime frameDescription
Power spectral density of EEG between interventions10 minutes after initiation of nasal airflowMean PSD will be calculated across beta, alpha, delta and gamma frequency bands and compared between TUI-1 and TUI-2
CoherenceBefore and 10 minutes after initiation of nasal airflowInter-regional EEG coherence will be quantified as a measure of functional connectivity

Countries

New Zealand

Contacts

CONTACTKelly Gradon
kelly.gradon@fphcare.co.nz09 574 0100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026